As some formularies begin to favor biosimilars, CVS Health and Cigna Group's Evernorth are veering further into the biosimilar business, The Wall Street Journal reported April 29. 

The term "hospital pharmacy" is becoming a misnomer.

In the first three months of 2024, the U.S. reached a record with 323 ongoing medication shortages — the highest number since 2001. 

West Reading, Pa.-based Tower Health recently promoted Stephanie Goldman, PharmD, from a hospital pharmacy leadership role to a systemwide job. 

Walgreens is expanding its specialty pharmacy offerings, including gene and cell therapy services, the company said April 25. 

Keytruda (pembrolizumab) was nonfederal hospitals' costliest drug expense in 2023, according to research published April 24 in the American Journal of Health-System Pharmacy. 

More than $38 billion was spent in the U.S. on Ozempic and Wegovy (semaglutide) in 2023 — a 100% uptick from 2022 expenditure data, according to research published April 24 in the American Journal of Health-System Pharmacy. 

The American Society of Health-System Pharmacists has named eight candidates for its board of directors.

Eli Lilly will acquire a Wisconsin-based injectable manufacturing facility from Nexus Pharmaceuticals, a drugmaker in Illinois. 

For about five years, federal auditors have enforced confusing requirements for residency programs, according to the American Society of Health-System Pharmacists, which released a toolkit April 18 to safeguard these programs.